See more : Legato Merger Corp. (LEGOU) Income Statement Analysis – Financial Results
Complete financial analysis of BioSenic S.A. (0R55.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioSenic S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Turbo Energy, S.A. American Depositary Shares (TURB) Income Statement Analysis – Financial Results
- Alignment Healthcare, Inc. (ALHC) Income Statement Analysis – Financial Results
- Eveready Industries India Limited (EVEREADY.BO) Income Statement Analysis – Financial Results
- Public Joint Stock Company Krasnoyarskenergosbyt (KRSB.ME) Income Statement Analysis – Financial Results
- PP Capital – Tactical Asset Allocation (PMICTAAKLNEUR.CO) Income Statement Analysis – Financial Results
BioSenic S.A. (0R55.L)
About BioSenic S.A.
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures. The company is based in Mont-Saint-Guibert, Belgium.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 543.00K | 266.00K | 1.00M | 1.00M | 0.00 | 1.00M | 41.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 60.00K | 13.00K | 0.00 | 228.00K | 0.00 | 522.00K | 534.00K | 392.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 543.00K | 206.00K | 987.00K | 1.00M | -228.00K | 1.00M | -481.00K | -534.00K | -392.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 77.44% | 98.70% | 100.00% | 0.00% | 100.00% | -1,173.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 3.93M | 1.03M | 11.68M | 15.42M | 11.19M | 12.88M | 13.12M | 13.65M | 12.91M | 7.96M | 6.82M | 6.37M |
| General & Administrative | 3.65M | 619.00K | 1.77M | 1.81M | 1.55M | 1.72M | 1.51M | 1.37M | 1.23M | 657.00K | 339.00K | 348.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.65M | 619.00K | 1.77M | 1.81M | 1.55M | 1.72M | 1.51M | 1.37M | 1.23M | 657.00K | 339.00K | 348.00K |
| Other Expenses | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.58M | 2.32M | 13.03M | 16.02M | 11.17M | 12.47M | 12.34M | 12.80M | 12.22M | 5.63M | 4.04M | 3.66M |
| Cost & Expenses | 7.58M | 2.32M | 13.03M | 16.02M | 11.17M | 12.47M | 12.34M | 12.80M | 12.22M | 5.63M | 4.04M | 3.66M |
| Interest Income | 59.00K | 3.00K | 25.00K | 23.00K | 26.00K | 66.00K | 198.00K | 173.00K | 193.00K | 124.00K | 150.00K | 172.00K |
| Interest Expense | 5.95M | 278.00K | 845.00K | 678.00K | 398.00K | 301.00K | 423.00K | 388.00K | 284.00K | 254.00K | 176.00K | 0.00 |
| Depreciation & Amortization | 234.00K | 60.00K | 13.00K | 173.00K | 228.00K | 580.00K | 522.00K | 534.00K | 394.00K | 371.00K | 407.00K | 402.00K |
| EBITDA | -6.80M | -2.26M | -864.00K | -14.83M | -6.69M | -13.13M | -11.65M | -12.17M | -13.07M | -5.18M | -3.50M | -3.15M |
| EBITDA Ratio | -1,251.57% | -851.88% | -1,180.50% | -1,447.50% | 0.00% | -1,309.30% | -28,239.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.04M | -2.32M | -12.03M | -15.02M | -11.17M | -11.47M | -12.29M | -12.80M | -12.22M | -5.63M | -4.04M | -3.66M |
| Operating Income Ratio | -1,296.50% | -871.43% | -1,202.60% | -1,501.70% | 0.00% | -1,146.60% | -29,985.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -21.99M | -731.00K | -107.00K | -737.00K | 3.65M | -2.55M | -297.00K | -291.00K | 964.00K | 3.18M | 3.37M | 3.02M |
| Income Before Tax | -29.03M | -3.05M | -12.84M | -15.75M | -10.30M | -14.01M | -12.59M | -13.08M | -14.03M | -5.81M | -4.07M | -3.70M |
| Income Before Tax Ratio | -5,345.86% | -1,146.24% | -1,283.60% | -1,575.40% | 0.00% | -1,401.10% | -30,709.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -7.00K | -1.02M | 89.00K | 78.00K | 38.00K | 131.00K | 178.00K | -60.00K | 61.00K | 49.00K | 180.00K | -9.00K |
| Net Income | -28.78M | -2.04M | -12.93M | -11.94M | -10.46M | -14.22M | -12.75M | -12.99M | -14.14M | -5.73M | -4.08M | -3.69M |
| Net Income Ratio | -5,299.82% | -767.29% | -1,292.50% | -1,194.00% | 0.00% | -1,421.80% | -31,102.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.21 | -0.02 | -0.61 | -1.02 | -1.10 | -1.87 | -1.86 | -1.90 | -2.14 | -1.69 | -1.34 | -1.07 |
| EPS Diluted | -0.21 | -0.02 | -0.61 | -1.02 | -1.10 | -1.87 | -1.86 | -1.90 | -2.14 | -1.69 | -1.34 | -1.07 |
| Weighted Avg Shares Out | 137.04M | 120.13M | 21.31M | 11.72M | 9.54M | 7.61M | 6.85M | 6.85M | 6.60M | 3.39M | 3.05M | 3.46M |
| Weighted Avg Shares Out (Dil) | 137.04M | 120.13M | 21.31M | 11.72M | 9.54M | 7.61M | 6.85M | 6.85M | 6.60M | 3.39M | 3.05M | 3.46M |
Source: https://incomestatements.info
Category: Stock Reports